Discover recent press, blog posts and announcements from Sequoia.
News
Sequoia Reinsurance Services offers a portfolio of reinsurance solutions to support companies as they work to manage medical risk and contain costs.
NSM Insurance Group Acquires ELMC Subsidiaries from J.C. Flowers…
Click here to download PDF
READ MORE
Self Insurer – Inflation Impacts Healthcare Costs and Self-Insured…
Click here to download PDF
READ MORE
FDA approves J&J’s BCMA-targeted bispecific for multiple myeloma
Click here to download PDF
READ MORE
Bluebird’s $2.8 million gene therapy becomes most expensive drug…
The U.S. Food and Drug Administration on Wednesday approved bluebird bio’s (BLUE.O) gene therapy for patients with a rare disorder…
READ MORE
Bristol’s Breyanzi wins broader FDA nod, bringing CAR-T showdown…
The FDA has cleared Breyanzi to treat newly relapsed or refractory large B-cell lymphoma, less than three months after Yescarta…
READ MORE
Phase 3 Trial of Hemophilia A Gene Therapy SB-525
Phase 3 Trial of Hemophilia A Gene Therapy SB-525
READ MORE
Novartis’ Kymriah fails to meet primary goal in non-Hodgkin…
Novartis’ Kymriah fails to meet primary goal in non-Hodgkin lymphoma trial
READ MORE
New data show BioMarin’s troubled hemophilia gene therapy continues…
New data show BioMarin’s troubled hemophilia gene therapy continues to fade, opening room for rivals – Endpoints News
READ MORE
Bluebird cleared by FDA to resume studies of sickle…
Bluebird cleared by FDA to resume studies of sickle cell gene therapy
READ MORE
FDA approval sets stage for a showdown between Alexion…
FDA approval sets stage for a showdown between Alexion and Apellis BioPharma Dive
READ MORE
FDA approves ADC Therapeutics antibody drug conjugate in B-cell…
FDA approves ADC Therapeutics antibody drug conjugate in B-cell lymphoma - MedCity News
READ MORE
U.S. Food and Drug Administration Approves Bristol Myers Squibbs…
U.S. Food and Drug Administration Approves Bristol Myers Squibbs and bluebird bios Abecma (idecabtagene vicleucel)
READ MORE
Gilead’s Kite keeps adding to CAR-T Yescarta’s bag of…
Gilead’s Kite keeps adding to CAR-T Yescarta’s bag of tricks
READ MORE
Bristol Myers finally wins FDA approval for cancer cell…
Bristol Myers finally wins FDA approval for cancer cell therapy
READ MORE
CMS Issues Final Rule to Empower States, Manufacturers, and…
CMS Issues Final Rule to Empower States, Manufacturers, and Private Payers
READ MORE
Sequoia Branch Industry Leading Client Savings 2020
Sequoia Branch Industry Leading Client Savings 2020
READ MORE
Sequoia Reinsurance Services LLC Announces Agreement with Everest Reinsurance…
Click here to download PDF.
READ MORE
Sequoia Presents: The Impact of COVID-19 – Focused Claims…
Sequoia Presents: The Impact of COVID-19 - Focused Claims Review with Optum
READ MORE
Mass. Outlines Deal For A $2 Million Drug: Pay…
Mass. Outlines Deal For A $2 Million Drug: Pay Only If It Works
READ MORE
Reinsurance Market Risk Drivers and Pipeline 2020
Provided Content is password protected. Click Read More!
READ MORE
Accessibility and Affordability of Gene Therapy
Accessibility and Affordability of Gene Therapy
READ MORE
Doctor offers unique perspective as father of a child…
Doctor offers unique perspective as father of a child with rare genetic disease
READ MORE
Sequoia Reinsurance Launches, Focused on HMO Reinsurance and Provider…
MINNEAPOLIS, June 14, 2018 /PRNewswire/ — Sequoia Reinsurance LLC (“Sequoia”) announced today that it has launched operations focused on HMO reinsurance and provider…
READ MORE
New Reinsurance Firm to Offer Some Employer Stop-Loss
A new, Minneapolis-based health reinsurance firm says it will offer specialized employer stop-loss arrangements, without defining exactly what those arrangements…
READ MORE
Something Happened to U.S. Drug Costs in the 1990s
Two decades ago, the costs began rising well beyond that of other nations, and in recent years have shot up…
READ MORE
Branch Program Claim Payment Integrity Review
Branch Program Claim Payment Integrity Review
READ MORE